Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 3 studies | 29% ± 9% |
Insufficient scRNA-seq data for expression of C2CD2L at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1250.14 | 1444 / 1445 | 100% | 5.71 | 183 / 183 |
brain | 100% | 3587.55 | 2632 / 2642 | 100% | 11.72 | 705 / 705 |
intestine | 100% | 1760.62 | 966 / 966 | 99% | 7.56 | 524 / 527 |
prostate | 100% | 1217.59 | 245 / 245 | 99% | 8.46 | 499 / 502 |
thymus | 100% | 1243.64 | 652 / 653 | 99% | 6.18 | 601 / 605 |
stomach | 100% | 1041.70 | 359 / 359 | 99% | 6.98 | 283 / 286 |
breast | 100% | 1031.79 | 459 / 459 | 99% | 10.00 | 1106 / 1118 |
pancreas | 100% | 1004.08 | 327 / 328 | 99% | 7.68 | 176 / 178 |
bladder | 100% | 1128.14 | 21 / 21 | 98% | 6.05 | 496 / 504 |
lung | 100% | 1810.82 | 576 / 578 | 99% | 6.74 | 1140 / 1155 |
ovary | 100% | 968.38 | 180 / 180 | 97% | 7.46 | 418 / 430 |
uterus | 100% | 1216.83 | 170 / 170 | 97% | 6.10 | 443 / 459 |
skin | 98% | 1832.32 | 1776 / 1809 | 98% | 7.96 | 463 / 472 |
kidney | 100% | 1574.65 | 89 / 89 | 95% | 4.64 | 859 / 901 |
adrenal gland | 100% | 1238.51 | 258 / 258 | 94% | 10.36 | 216 / 230 |
liver | 100% | 1051.53 | 225 / 226 | 88% | 3.61 | 356 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 8.27 | 29 / 29 |
spleen | 100% | 2429.07 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 4.32 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.50 | 1 / 1 |
adipose | 100% | 1076.28 | 1199 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1054.06 | 1327 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 1339.81 | 797 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 1351.81 | 910 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 918.70 | 836 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 85% | 3.53 | 68 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0120009 | Biological process | intermembrane lipid transfer |
GO_0015914 | Biological process | phospholipid transport |
GO_0035774 | Biological process | positive regulation of insulin secretion involved in cellular response to glucose stimulus |
GO_0032541 | Cellular component | cortical endoplasmic reticulum |
GO_0098592 | Cellular component | cytoplasmic side of apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0140268 | Cellular component | endoplasmic reticulum-plasma membrane contact site |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0043559 | Molecular function | insulin binding |
GO_0008526 | Molecular function | phosphatidylinositol transfer activity |
GO_0005515 | Molecular function | protein binding |
GO_0035091 | Molecular function | phosphatidylinositol binding |
Gene name | C2CD2L |
Protein name | C2CD2 like Phospholipid transfer protein C2CD2L (C2 domain-containing protein 2-like) (C2CD2-like) (Transmembrane protein 24) C2CD2L protein |
Synonyms | DLNB23 KIAA0285 TMEM24 |
Description | FUNCTION: Lipid-binding protein that transports phosphatidylinositol, the precursor of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), from its site of synthesis in the endoplasmic reticulum to the cell membrane . It thereby maintains the pool of cell membrane phosphoinositides, which are degraded during phospholipase C (PLC) signaling . Plays a key role in the coordination of Ca(2+) and phosphoinositide signaling: localizes to sites of contact between the endoplasmic reticulum and the cell membrane, where it tethers the two bilayers . In response to elevation of cytosolic Ca(2+), it is phosphorylated at its C-terminus and dissociates from the cell membrane, abolishing phosphatidylinositol transport to the cell membrane . Positively regulates insulin secretion in response to glucose: phosphatidylinositol transfer to the cell membrane allows replenishment of PI(4,5)P2 pools and calcium channel opening, priming a new population of insulin granules . . |
Accessions | E9PK05 ENST00000528586.2 Q9BTM2 O14523 ENST00000336702.7 [O14523-2] ENST00000648610.2 [O14523-1] Q6DHX1 |